Effects of gabexate mesilate (FOY) on amylase and phospholipase A 2 in human serum and pancreatic juice

Digestive Diseases and Sciences

Volumn 50, Issue 5, 2005, Pages 868-873

  Caronna, Roberto ^a   Diana, Loretta ^b   Nofroni, Italo ^a   Sibio, Simone ^a   Catinelli, Stefania ^c   Sammartino, Paolo ^a   Chirletti, Piero ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

Enzyme inhibition; Gabexate mesilate; Pancreatic secretion

Indexed keywords

AMYLASE; GABEXATE MESILATE; OCTREOTIDE; PHOSPHOLIPASE A2;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; PANCREAS FISTULA; PANCREAS JUICE; PANCREAS SECRETION; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SURGICAL DRAINAGE;

AMYLASES; FOLLOW-UP STUDIES; GABEXATE; HUMANS; PANCREAS; PANCREATIC JUICE; PHOSPHOLIPASES A; POSTOPERATIVE PERIOD; SERINE PROTEINASE INHIBITORS; TIME FACTORS;

EID: 18844404875     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2655-0     Document Type: Article

References (29)

1. Kitagawa M, Naruse S, Ishiguro H, Hayakawa T: Pharmaceutical development for treating pancreatic diseases. Pancreas 16:427-431, 1998
2. Bassi C, Falconi M, Caldiron E, Salvia R, Sartori N, Butturini G, Contro C, Marcucci S, Casetti L, Pederzoli P: Assessment and treatment of severe pancreatitis. Protease inhibitor. Digestion 60 (Suppl 1):5-8, 1999
3. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I: Diagnosis, objective assessment of severity and management of acute pancreatitis. Int J Pancreatol 25:195-210, 1999
4. Trapnell JE, Rigby CC, Talbot CH, Duncan EH: A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg 61(3): 177-182, 1974
5. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, Blumgart LH: A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 65:337-341, 1978
6. Harada H, Miyake H, Ochi K, Tanaka J, Kimura I: Clinical trial with a protease inhibitor Gabexate Mesilate in acute pancreatitis. Int J Pancreatol 9:75-79, 1991
7. Valderrama R, Pèrez-Mateo M, Navarro S, Vázquez N, Sanjosé L, Adrián MJ, Estruch J: Multicenter double-blind trial of gabexate-mesilate (FOY) in unselected patients with acute pancreatitis. Digestion 51:65-70, 1992
8. Buchler M, Malfertheiner P, Uhl W, Scholmerich J, Stockmann F, Adler G, Gaus W, Rolle K, Beger HG: Gabexate mesilate in human acute pancreatitis. Gastroenterology 104:1165-1170; 1993
9. Messori A, Rampazzo R, Scroccaro G, Olivato R, Bassi C, Falconi M, Pederzoli P, Martini N: Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sci 40(4):734-738, 1995
10. Pederzoli P, Cavallini G, Falconi M, Bassi C: Gabexate mesilate vs aprotinin in human acute pancreatitis. Int J Pancreatol 2:117-124, 1993
11. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 335:919-923, 1996
12. Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, Lezzi C, Lichino E, Bruno F, Perri F: Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12:237-245, 1998
13. Tanaka N, Tsuchiya, Ishii K: Comparative clinical study of FOY and Trasylol in acute pancreatitis. Adv Exp Med Biol 120B:367-368, 1979
14. Okegawa T, Fujita T, Yamamoto Y, Nakai H, Miyamoto K, Matsumoto K, Tani S: Effects of FOY on experimental acute pancreatitis. Curr Med 6:1-10, 1974
15. Caronna R, Diana L, Di Giavannandrea R, Campedelli P, Catinelli S, Nofroni I, Sibio S, Chirletti P: Gabexate mesilate (FOY) inhibition of amylase and phospholipase A2 activity in sow pancreatic juice. J Invest Surg 16:345-351, 2003
16. Hoffman GE, Schmidt D, Bastian B, Guder WG: Photometric determination of phospholipase A. J Clin Biochem 24 (11):871-875, 1986
17. Di Giovannandrea R, Diana L, Fiori M, Ferretti E, Foglietta G, Caronna R, Severini G: Determination of ethyl-p-hydroxybenzoate in sow pancreatic juice by reversed-phase high-performance liquid chromatography. J Chromatogr B 751:365-369, 2001
18. Keim K, Goke B: Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor gabexate mesilate. Eur J Clin Invest 16:519-525, 1986
19. Freise J, Melzer P, Schmidt FW, Horbach L: Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients. Z Gastroenterol 24(4):200-211, 1986
20. Freise J, Schmidt FW, Magerstedt P, Schmid K: Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Clin Biochem 18(4):224-229, 1985
21. Gronroos JM, Nevalainen TJ: Phospholipase A2 in acute pancreatitis: clinical value of phospholipase A2 measurements. Prog Surg 24:182-186, 1997
22. Arbibe L, Vial D, Touqui L: Phospholipase A2 and acute respiratory distress syndrome. Prog Surg 24:79-87, 1997
23. Uhl W, Buchler MW: Phospholipase A2 in surgical intensive care patients. Prog Surg 24:187-199, 1997
24. Royston D: Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass. J Cardiovasc Pharmacol 27 (Suppl 1):S42-S49, 1996
25. Watanabe S: Acute pancreatitis:overview of medical aspects. Pancreas 16(3):307-311, 1998
26. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S: Synthetic inhibitors of trypsin, kallicrein, thrombin, C1r and C1esterase. Biochim Biophys Acta 484:417-422, 1977
27. Baxter JN, Jenkins SA, Day DW, Roberts NB, Cowell DC, Mackie CR, Shields R: Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg 72:382-385, 1985
28. McKay CJ, Imrie CW, Baxter JN: Somatostatin and somatostatin analogues - Are they indicated in the management of acute pancreatitis? Gut 34:1622-1626, 1993
29. Lamberts SWJ, Van Der Lely A, De Herder WW, Hofland LJ: Octreotide. N Engl J Med 334(4):246-254, 1996